Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RA Capital
Biotech
CellCentric raises $220M to advance myeloma drug
In the last three years, CellCentric CEO Will West has been on a journey that has transformed how he thinks about the future of his company.
Will Maddox
May 6, 2026 7:00am
Windward breezes toward phase 3 with $165M for TSLP ambitions
May 4, 2026 10:31am
Stipple Bio debuts with $100M to advance oncology asset
Apr 6, 2026 7:00am
Candid scores Nasdaq listing via reverse merger Rallybio
Mar 2, 2026 11:45am
Sensei steps back from brink by finding Faeth merger
Feb 18, 2026 10:33am
ILiAD advances whooping cough vaccine with $115M raise
Feb 10, 2026 8:00am
